A. Pezzolo

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
A Pezzolo, A. Pezzolo, Annalisa Pezzolo
Publication record
89 papers · 2,469 citations · H-index 26

PAPERS

Overexpression of H2AFX gene in neuroblastoma is associated with worse prognosis
20241 citationsauthor #5
Multiple Genes with Potential Tumor Suppressive Activity Are Present on Chromosome 10q Loss in Neuroblastoma and Are Associated with Poor Prognosis
20235 citationsauthor #7
A Simple, Test-Based Method to Control the Overestimation Bias in the Analysis of Potential Prognostic Tumour Markers
20230 citationsauthor #2
Neuroblastoma Patients’ Outcome and Chromosomal Instability
20233 citationsauthor #7
E2F3 gene expression is a potential negative prognostic marker for localised and MYCN not‐amplified neuroblastoma: Results of in silico analysis of 786 samples
20224 citationsauthor #6
Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4
20229 citationsauthor #7
High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene TSSC1
20212 citationsauthor #7
Molecular Genetics in Neuroblastoma Prognosis
202124 citationsauthor #3
Exosomes from Plasma of Neuroblastoma Patients Contain Doublestranded DNA Reflecting the Mutational Status of Parental Tumor Cells
202124 citationsauthor #13
Enhancement of Neuroblastoma NK-Cell-Mediated Lysis through NF-kB p65 Subunit-Induced Expression of FAS and PVR, the Loss of Which Is Associated with Poor Patient Outcome
20218 citationsauthor #3
19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis
202020 citationsauthor #9
The Over-Expression of E2F3 Might Serve as Prognostic Marker for Neuroblastoma Patients with Stage 4S Disease
20207 citationsauthor #4
Identification of a minimal region of loss on chromosome 6q27 associated with poor survival of high-risk neuroblastoma patients
202018 citationsauthor #5
Nutlin-3a Enhances Natural Killer Cell–Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors
202040 citationsauthor #12
Roniciclib down-regulates stemness and inhibits cell growth by inducing nucleolar stress in neuroblastoma
20208 citationsauthor #2
19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis
20202 citationsauthor #9
Ezrin interacts with the tumor suppressor CHL1 and promotes neuronal differentiation of human neuroblastoma
20206 citationsauthor #2
The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma
201923 citationsauthor #17
Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study ‖
201949 citationsauthor #14
The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma
20190 citationsauthor #17
Loss of whole chromosome X predicts prognosis of neuroblastoma patients with numerical genomic profile
201914 citationsauthor #10
Correction to: The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma
20190 citationsauthor #17
Correction to: The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma
20194 citationsauthor #17
Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients
201929 citationsauthor #13
Role of GOLPH3 and TPX2 in Neuroblastoma DNA Damage Response and Cell Resistance to Chemotherapy
201922 citationsauthor #4
Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors
20188 citationsauthor #4
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model
201896 citationsauthor #8
CHL1 gene acts as a tumor suppressor in human neuroblastoma
201829 citationsauthor #13
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma
201745 citationsauthor #4
Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma
201712 citationsauthor #1
Involvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based Immunotherapy
201624 citationsauthor #2
A Promyelocytic Leukemia Protein–Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma
20168 citationsauthor #4
XTENS: a neuroblastoma copy number variation repository at the BIT-Gaslini biobank
20160 citationsauthor #3
Isolation and characterization of renal cancer stem cells from patient-derived xenografts
201521 citationsauthor #10
Retraction. The IL-12Rβ2 gene functions as a tumor suppressor in human B cell malignancies.
20140 citationsauthor #6
Telomere shortening and increased oxidative stress are restricted to venous tissue in patients with varicose veins: A merely local disease?
20147 citationsauthor #4
Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia
201418 citationsauthor #1
Intratumoral diversity of telomere length in individual neuroblastoma tumors
201440 citationsauthor #1
Immunosuppressive Microenvironment in Neuroblastoma
201372 citationsauthor #4
Proteome Profiling of Neuroblastoma-Derived Exosomes Reveal the Expression of Proteins Potentially Involved in Tumor Progression
2013145 citationsauthor #4
Endothelial and Smooth Muscle Cells from Abdominal Aortic Aneurysm Have Increased Oxidative Stress and Telomere Attrition
2012104 citationsauthor #10
MYCN: from oncoprotein to tumor-associated antigen
201218 citationsauthor #3
Intracranial Pediatric Ependymoma: Role of Cytogenetic Markers Using Comparative Genomic Hybridization and Fluorescent In Situ Hybridization
20120 citationsauthor #1
Loss of 10q26.1-q26.3 in association with 7q34-q36.3 gain or 17q24.3-q25.3 gain predict poor outcome in pediatric medulloblastoma.
20118 citationsauthor #1
Identification of Novel Prognostic Markers in Relapsing Localized Resectable Neuroblastoma
20116 citationsauthor #9
Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells
201171 citationsauthor #1
Treatment of newborn G6pc(-/-) mice with bone marrow-derived myelomonocytes induces liver repair.
20117 citationsauthor #8
Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas
201170 citationsauthor #3
Presence of 1q gain and absence of 7p gain are new predictors of local or metastatic relapse in localized resectable neuroblastoma.
200931 citationsauthor #1
The Combined Therapeutic Effects of Bortezomib and Fenretinide on Neuroblastoma Cells Involve Endoplasmic Reticulum Stress Response
200948 citationsauthor #7
Bronchial airway epithelial cell damage following exposure to cigarette smoke includes disassembly of tight junction components mediated by the extracellular signal-regulated kinase 1/2 pathway.
2009101 citationsauthor #6
232 POSTER Combined therapeutic effects of bortezomib and fenretinide on Neuroblastoma cell growth, apoptosis, and angiogenesis
20080 citationsauthor #4
Combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cell growth and apoptosis
20080 citationsauthor #8
Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma.
200822 citationsauthor #1
1403 ORAL Fenretinide enhances the antitumour efficacy of bortezomib on human neuroblastoma cells
20070 citationsauthor #7
Modulation of human lung fibroblast functions by ciclesonide: evidence for its conversion into the active metabolite desisobutyryl-ciclesonide.
200719 citationsauthor #6
Tumor origin of endothelial cells in human neuroblastoma.
2007136 citationsauthor #1
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice
200756 citationsauthor #5
Combined Therapeutic Effects of Vinblastine and Rapamycin on Human Neuroblastoma Growth, Apoptosis, and Angiogenesis
200777 citationsauthor #5
Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-γ
200643 citationsauthor #3
Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome
200623 citationsauthor #6
Chromosomal imbalances in pediatric Burkitt-like lymphoma and review of the literature in relation to other germinal center derived B-cell tumors
20064 citationsauthor #1
Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis.
2006139 citationsauthor #9
Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.
2006233 citationsauthor #5
Rhabdoid meningioma of the tentorium with expression of desmin in a 12-year-old Turner syndrome patient
200521 citationsauthor #5
The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies.
200426 citationsauthor #6
The IL-12Rβ2 gene functions as a tumor suppressor in human B cell malignancies
200453 citationsauthor #6
Induction of Apoptosis by Flavopiridol in Human Neuroblastoma Cells Is Enhanced under Hypoxia and Associated With N-myc Proto-oncogene Down-Regulation
200424 citationsauthor #4
A novel case of immunodeficiency, centromeric instability, and facial anomalies (the ICF syndrome): immunologic and cytogenetic studies.
200213 citationsauthor #1
T-cell apoptosis in ICF syndrome.
200116 citationsauthor #1
Late Epstein-Barr virus infection of a hepatosplenic T-cell lymphoma arising in a kidney transplant recipient
20006 citationsauthor #5
Analysis of stepwise genetic changes in an AIDS‐related Burkitt's lymphoma
20006 citationsauthor #7
Late Epstein-Barr virus infection of a hepatosplenic gamma delta T-cell lymphoma arising in a kidney transplant recipient.
200038 citationsauthor #5
Prenatal diagnosis of triploidy using fetal cells in the maternal circulation
199719 citationsauthor #1
[Prenatal diagnosis of triploidy and trisomy 21 through fetal erythroblasts isolated from maternal blood].
19972 citationsauthor #1
The phenotype of a 45, X male with a Y/18 translocation
199616 citationsauthor #6
Maternal derivation of inv dup (22) and clinical variation in cat-eye syndrome.
19944 citationsauthor #3
Definitive assignment of the growth hormone-releasing factor gene to 20q11.2
19943 citationsauthor #1
Erratum: Fine mapping and cloning of the breakpoint associated with Menkes syndrome in a female patient (Genomics (1992) 14 (557-561))
19931 citationsauthor #6
ICF syndrome with variable expression in sibs.
199339 citationsauthor #3
Identification of ring Y chromosome: cytogenetic analysis, Southern blot and fluorescent in situ hybridization.
19937 citationsauthor #1
Cytogenetics of multiple endocrine neoplasia syndromes. III. Analysis of an insulinoma from a subject with MEN 1 by chromosome painting.
19934 citationsauthor #2
Are the nail-patella syndrome and the autosomal Goltz-like syndrome the phenotypic expressions of different alleles at the COL5A1 locus?
19936 citationsauthor #4
Presence of telomeric and subtelomeric sequences at the fusion points of ring chromosomes indicates that the ring syndrome is caused by ring instability
199361 citationsauthor #1
ICFsyndrome withvariable expression insibs
19930 citationsauthor #2
Mapping of the human COL5A1 gene to chromosome 9q34.3
199216 citationsauthor #2
Molecular and cytogenetic characterization of radiation hybrids specific for human chromosome 16.
19920 citationsauthor #2
Fine mapping and cloning of the breakpoint associated with Menkes syndrome in a female patient.
19928 citationsauthor #6
First trimester fetal karyotyping: one thousand diagnoses
198618 citationsauthor #9

TIMELINE

1986 18 citations

1992 24 citations

1993 118 citations

1994 7 citations

1996 16 citations

1997 21 citations

2000 50 citations

2001 16 citations

2002 13 citations

2004 103 citations

2005 21 citations

2006 442 citations

2007 288 citations

2008 22 citations

2009 180 citations

2011 162 citations

2012 122 citations

2013 217 citations

2014 65 citations

2015 21 citations

2016 32 citations

2017 57 citations

2018 133 citations

2019 141 citations

2020 101 citations

2021 58 citations

2022 13 citations

2023 8 citations

2024 1 citations

COAUTHOR MAP

CONCEPT FOOTPRINT